Drug Approval | June 30, 2022
India’s first mRNA vaccine from Gennova gets DCGI approval
It is a two dose vaccine to be administered intramuscularly at 28 days apart
It is a two dose vaccine to be administered intramuscularly at 28 days apart
Both vaccine candidates demonstrated a favorable safety and tolerability profile similar to the Pfizer-BioNTech COVID-19 Vaccine
Dr. Rizo brings extensive industry leadership experience to Vividion, having held multiple senior executive roles during her career at both biotechnology and large pharmaceutical companies.
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
With this designation, LG Chem will receive benefits such as exclusive sales rights in the US market for seven years, subsidies and tax cuts for clinical testing costs in the US, and preliminary consulting support related to development
Redbiotec has a right to royalties on Eurocine Vaccines´ net sales of an approved HSV-2 vaccine, should such sales arise.
Based on a post hoc analysis, fewer required respiratory interventions
Co-marketing agreement between Thermo Fisher Scientific and TransMIT allows for high spatial and high mass resolution MSI platform to study complex biological tissues
Subscribe To Our Newsletter & Stay Updated
